Takero Shindo - Concepedia

Author

Takero Shindo

Kyoto University ORCID

Also Known As

Akihisa Kawajiri, Shindo, Takero, T Shindo, T. Shindo, Takahiro Fukuda, Takero SHINDO, Takero Shindo

144

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Kyoto University Saga University Kyoto University Hospital Hiroshima University National Sagamihara Hospital

About

Takero Shindo is an author at Kyoto University specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	212
2	Health Sciences	2	2	101
3	Public Health	1	1	12
4	Cell Biology	1	1	25
5	Cellular Therapies	1	1	25

Takero Shindo

Publications

765

Citations

H-Index

Page 1

	Year	Citations
Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations Sumie Fujii, Yasuo Miura, Aya Fujishiro, Stem Cells	2017	212
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease Nobukatsu Sawamoto, Daisuke Doi, Etsuro Nakanishi, Nature	2025	85
MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner Takero Shindo, Tae Kon Kim, Cara L. Benjamin, Blood	2013	52
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results Shinya Rai, Won Seog Kim, Kiyoshi Ando, Haematologica Phase Iib ResultsHematological MalignancyLymphoid NeoplasiaHistone DeacetylaseMedicine	2022	51
Clinical impact of the CONUT score in patients with multiple myeloma Sho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, Annals of Hematology Hematological MalignancyHealth SciencesMedicineHematologyConut Score	2019	50
Allelic Polymorphisms of <i>KIR</i> s and <i>HLA</i> s Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML Hiroshi Ureshino, Takero Shindo, Hiroto Kojima, Cancer Immunology Research	2018	36
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia Hiroshi Ureshino, Takero Shindo, Hiroyoshi Nishikawa, Cancer Immunology Research	2016	31
Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg Hidekazu Itamura, Yasushi Kubota, Takero Shindo, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyElderly PatientsGeriatricsMedicineHematology	2017	29
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma Hiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, Annals of Hematology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyConut Score	2018	29
Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy Hiroshi Okamura, Hirohisa Nakamae, Takero Shindo, Frontiers in Immunology	2021	27

Page 1